Zacks Investment Research Upgrades NISSAN CHEM IND/ADR (OTCMKTS:NNCHY) to Hold

Share on StockTwits

Zacks Investment Research upgraded shares of NISSAN CHEM IND/ADR (OTCMKTS:NNCHY) from a sell rating to a hold rating in a research report report published on Thursday, Zacks.com reports.

According to Zacks, “Nissan Chemical Corporation is a chemical manufacturing company. It offers melamine, sulfuric acid, nitric acid and ammonia; fine chemicals, including special epoxy, flame retardant and disinfectant. Nissan Chemical Corporation, formerly known as Nissan Chemical Industries Ltd., is based in Tokyo, Japan. “

OTCMKTS NNCHY opened at $45.19 on Thursday. The company has a quick ratio of 1.90, a current ratio of 3.10 and a debt-to-equity ratio of 0.01. The company has a market capitalization of $6.73 billion, a PE ratio of 25.39, a PEG ratio of 2.26 and a beta of 0.53. NISSAN CHEM IND/ADR has a 1 year low of $41.85 and a 1 year high of $54.81. The business has a 50-day simple moving average of $43.25.

NISSAN CHEM IND/ADR (OTCMKTS:NNCHY) last posted its quarterly earnings data on Wednesday, May 15th. The company reported $0.64 earnings per share for the quarter. The firm had revenue of $572.13 million for the quarter. As a group, equities analysts anticipate that NISSAN CHEM IND/ADR will post 2 EPS for the current year.

About NISSAN CHEM IND/ADR

Nissan Chemical Corporation engages in chemicals, performance materials, agricultural chemicals, pharmaceuticals, and advanced materials and planning businesses in Japan and internationally. Its chemical products include MELAMINE, an adhesive agent; high purity chemicals; AdBlue, a urea solution; FINEOXOCOL, a saturated fatty alcohol and acid; ammonia, sulfuric, and nitric acid; TEPIC, an epoxy compound; Melamine Cyanurate, a flame retardant; Nissan Reishi, a health food; phenylphosphonic acid, a surface modifier; HI-LITE, a chlorinated isocyanulate; and OPTBEADS, a melamine-formaldehyde resin and silica.

Recommended Story: SEC Filing

Get a free copy of the Zacks research report on NISSAN CHEM IND/ADR (NNCHY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for NISSAN CHEM IND/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NISSAN CHEM IND/ADR and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.